1. Home
  2. SNFCA vs LUNG Comparison

SNFCA vs LUNG Comparison

Compare SNFCA & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNFCA
    SELLHOLDBUYas of 2 days ago
  • LUNG
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • SNFCA 1965
  • LUNG 1995
  • Country
  • SNFCA United States
  • LUNG United States
  • Employees
  • SNFCA N/A
  • LUNG N/A
  • Industry
  • SNFCA Finance: Consumer Services
  • LUNG Industrial Specialties
  • Sector
  • SNFCA Finance
  • LUNG Health Care
  • Exchange
  • SNFCA Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • SNFCA 285.8M
  • LUNG 243.2M
  • IPO Year
  • SNFCA N/A
  • LUNG 2020
  • Fundamental
  • Price
  • SNFCA $12.07
  • LUNG $6.55
  • Analyst Decision
  • SNFCA
  • LUNG Buy
  • Analyst Count
  • SNFCA 0
  • LUNG 6
  • Target Price
  • SNFCA N/A
  • LUNG $11.92
  • AVG Volume (30 Days)
  • SNFCA 35.5K
  • LUNG 235.1K
  • Earning Date
  • SNFCA 11-14-2024
  • LUNG 02-19-2025
  • Dividend Yield
  • SNFCA N/A
  • LUNG N/A
  • EPS Growth
  • SNFCA N/A
  • LUNG N/A
  • EPS
  • SNFCA 1.23
  • LUNG N/A
  • Revenue
  • SNFCA $330,162,091.00
  • LUNG $79,302,000.00
  • Revenue This Year
  • SNFCA N/A
  • LUNG $22.26
  • Revenue Next Year
  • SNFCA N/A
  • LUNG $18.72
  • P/E Ratio
  • SNFCA $9.80
  • LUNG N/A
  • Revenue Growth
  • SNFCA N/A
  • LUNG 22.34
  • 52 Week Low
  • SNFCA $6.19
  • LUNG $5.46
  • 52 Week High
  • SNFCA $13.59
  • LUNG $14.84
  • Technical
  • Relative Strength Index (RSI)
  • SNFCA 48.13
  • LUNG 51.88
  • Support Level
  • SNFCA $11.81
  • LUNG $6.14
  • Resistance Level
  • SNFCA $12.49
  • LUNG $7.15
  • Average True Range (ATR)
  • SNFCA 0.41
  • LUNG 0.34
  • MACD
  • SNFCA -0.11
  • LUNG 0.06
  • Stochastic Oscillator
  • SNFCA 35.42
  • LUNG 58.04

Stock Price Comparison Chart: SNFCA vs LUNG

SNFCA
LUNG
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250510152025303540455055606570SNFCA VS LUNG

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use